🇨🇦 SGLT2i, beta blocker, ARNI, MRA, MTD in Canada

SGLT2i, beta blocker, ARNI, MRA, MTD (SGLT2i, beta blocker, ARNI, MRA, MTD) regulatory status in Canada.

Marketing authorisation

SGLT2i, beta blocker, ARNI, MRA, MTD in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is SGLT2i, beta blocker, ARNI, MRA, MTD approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for SGLT2i, beta blocker, ARNI, MRA, MTD in Canada?

Brigham and Women's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.